Contract

Strategic Category Lead

Contract Development & Manufacturing

Posted on 8/15/2025

GE Healthcare

GE Healthcare

1-10 employees

Imaging, monitoring, and healthcare IT solutions

No salary listed

Beaconsfield, UK

Hybrid

Category
Operations & Logistics (2)
,
Requirements
  • Bachelor’s degree (or equivalent) in a relevant subject, together with significant industry experience.
  • Experience in category management and sourcing along with defining and delivering effective category strategies which achieved significant cost transformations.
  • Experience in pharmaceutical research, drug product development, R&D, compliance and supplier vendor management.
  • Experience and having an active network within a pharmaceutical CDMO or CMO environment would be an advantage.
  • Strong Interpersonal and leadership skills.
  • Established project management skills.
  • Strong business acumen and capacity to understand complex industry dynamics (supplier/partner/product relationships).
  • Excellent communication skills and ability to interact and partner with all levels of management in the company.
  • Project management skills to execute complex projects with multiple stakeholders.
  • Fast learner: ability to learn enough of a complex industry and products to interact with highly technical experts, internal stakeholders and lead discussions, negotiations.
  • Inclusiveness: ability to partner, support and listen and influence a wide array of internal and external.
  • Ability to energize, develop and build rapport at all levels within an organization.
  • Willing to travel internationally up to 15% of time.
Responsibilities
  • As an integral member of the PDx Sourcing and R&D teams you will be responsible for developing and maintaining a lean and strategic approach to our supplier management for the R&D Contract Development and Manufacturing Organization (CDMO) supply base.
  • Ensure all activities with external vendors are awarded and maintained in compliance with Good Manufacturing Practice, Standard Operating Procedures, and Corporate Policies, Guidelines and Standards.
  • Responsible for maintaining internal collaboration between R&D, Product Management, Supply Chain & Direct material Sourcing (commercial launch planning), Quality and Regulatory organisations within the PDx business.
  • Responsible for supporting of new suppliers onto the Approved Supplier List for the current and future business needs, identifying gaps and identifying suitable suppliers to address the business need both regionally and globally.
  • Execute agreed strategic sourcing strategy within the category and sub-categories to develop appropriate contracting frameworks to commercially capture the outputs, and manage all ongoing performance against live agreements.
  • Support and manage the identification and selection process of vendors such as active pharmaceutical ingredient (API) manufacture, formulation development, drug product manufacturing, clinical trial supply services, analytical chemistry services and other CDMOs that support the drug development process.
  • Generates Requests for Information (RFI), Request for Quotations (RFQ) and Requests for Proposals (RFP).
  • Coordinates bid defenses and proposal review meetings and provides analysis to project teams.
  • Contract lifecycle management: including support the drafting and management of R&D contracts and change orders, including active negotiation of scope of work, payment terms and budgets.
  • Works with the R&D CMC Project teams and R&D Operations team, Clinical Project Directors, Global Program Leaders and Contract Managers and or the Legal Team to support requirements and contractual needs and Change Orders.
  • Works with Finance on budget/forecasting needs, cash flow, project budgets, etc.
  • In partnership with the Quality and Supplier Quality organisations, ensures quality oversight of suppliers.
  • Developing and maintain relationships with external partners, ensuring ongoing feedback and issue escalation is performed where needed.
  • Measure’s supplier performance utilizing Key Performance Indicators (KPIs), Scorecard/Metric activities; and communicating feedback to the supplier, encourage adaptation on best practices across supplier types and development of continuous process improvements/ maintenance.
  • Support supplier governance meetings and operating reviews.
  • Develops effective partnerships with suppliers and internal stakeholders.
  • Identifies current trends in practices in the industry and develops a strategy around these trends that is then well communicated to internal stakeholders and implemented.
  • Supports and contributes to complex functional or company initiatives and special projects as identified by executive management or business need.
Desired Qualifications
  • Experience and having an active network within a pharmaceutical CDMO or CMO environment would be an advantage.

GE Healthcare Systems provides medical technologies and digital infrastructure to improve diagnosis, treatment, and monitoring of patients. Its products include imaging systems, mobile diagnostic devices, patient monitoring tools, and healthcare IT software that work together as hardware, software, and services to support hospitals, clinics, and researchers. The company differentiates itself with a large, integrated ecosystem, strong focus on AI analytics, and a global service network backed by substantial R&D investment. Its goal is to improve patient outcomes and the efficiency of healthcare delivery by enabling accurate diagnoses, effective treatments, and scaled operations.

Company Size

1-10

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

1892

Simplify Jobs

Simplify's Take

What believers are saying

  • $2.3B Intelerad acquisition boosts cloud imaging amid $5.1B Q1 2026 revenue.
  • DeepHealth AI partnership lifts breast cancer detection 21% globally.
  • $21.8B backlog and supply chain shifts sustain 3-4% organic growth.

What critics are saying

  • Siemens Cios Alpha erodes CT share with superior resolution by Q2 2027.
  • Canon Vantage Galan captures MRI contracts 20-30% cheaper in 6-12 months.
  • FTC probe forces Intelerad divestitures, costing $300-500M by Q1 2027.

What makes GE Healthcare unique

  • GE HealthCare's four divisions span imaging, ultrasound, patient care, and pharmaceutical diagnostics.
  • Bangalore's $50M R&D center drives innovations across 100+ countries.
  • Photonova Spectra's Deep Silicon detectors enable 8-bin energy resolution CT imaging.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at GE Healthcare who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Relocation Assistance

Company News

The Associated Press
Apr 9th, 2026
GE HealthCare integrates bkActiv ultrasound with Medtronic Stealth AXiS for real-time cranial surgery navigation

GE HealthCare has announced a digital integration between its bkActiv intraoperative ultrasound system and Medtronic's Stealth AXiS surgical navigation system, now commercially available for cranial procedures. The integration allows neurosurgeons to use bkActiv as a plug-and-play real-time visualisation solution during procedures. The system addresses "brain shift", a natural movement of the brain during surgery that reduces pre-surgical image accuracy. bkActiv provides live ultrasound images alongside pre-operative MRI or CT scans on the Stealth AXiS system, recently cleared by the FDA for cranial procedures in the United States. Features include sterilisable transducers, sensitive colour Doppler for blood flow visualisation, and remote control capability from the sterile field. The companies will showcase the integration at the American Association of Neurological Surgeons Annual Scientific Meeting in May 2026.

Business Wire
Mar 25th, 2026
GE HealthCare unveils photon-counting CT and ReadyFix fleet management at ACC.26

GE HealthCare is showcasing its cardiology portfolio at ACC.26, featuring AI-enabled imaging technologies and software solutions addressing cardiovascular disease, which kills over 900,000 Americans annually. The company received US FDA 510(k) clearance for Photonova Spectra, a photon-counting CT system with proprietary Deep Silicon detectors designed to provide ultra-high-definition cardiac imaging and improved plaque characterisation. GE HealthCare introduced ReadyFix fleet management solution for MAC VU360 ECG workstations, enabling remote diagnostics and software deployment to optimise device uptime. The company also announced a US collaboration with Gentuity, connecting customers with HF-OCT and Vis-Rx PRIME Micro-Imaging Catheter for enhanced coronary procedure visualisation. The $20.6 billion company serves patients globally with imaging, diagnostics and AI solutions across the cardiology care pathway.

Business Wire
Mar 23rd, 2026
GE HealthCare's photon-counting CT Photonova Spectra receives FDA clearance

GE HealthCare has received FDA 510(k) clearance for Photonova Spectra, a photon-counting computed tomography system powered by its Deep Silicon detector technology. The system directly counts individual photons and measures their energy, enabling higher spectral and spatial resolution compared to conventional CT systems that first convert X-rays into visible light. Photonova Spectra features 8-bin energy resolution, wide detector coverage and rapid 0.23-second rotation speed, supporting fast acquisition and detailed visualisation across multiple clinical specialties. The system automatically captures spectral and ultra-high definition spatial data simultaneously without requiring special protocols. The technology incorporates NVIDIA accelerated computing to process up to 50 times more data than conventional CT systems. GE HealthCare is collaborating with institutions including UW-Madison and Stanford Medicine to explore clinical applications and imaging protocols.

Yahoo Finance
Mar 17th, 2026
GE HealthCare appoints Stryker CEO Kevin Lobo to board of directors

GE HealthCare has appointed Kevin Lobo, chair and CEO of Stryker Corporation, to its board of directors effective 13 March. Lobo brings over 25 years of medical technology, operational and financial leadership experience to the role. Lobo has served as Stryker's CEO since October 2012 and board chair since July 2014. Previously, he held leadership positions at Johnson & Johnson, including president of Ethicon Endo Strategy, and at chemical and pharmaceutical company Rhône-Poulenc. His early career included finance roles at KPMG, Unilever and Kraft Canada. GE HealthCare chairman H. Lawrence Culp said Lobo's clinical expertise and track record of driving innovation would strengthen the board as the company pursues growth priorities in personalised, connected healthcare.

Yahoo Finance
Mar 16th, 2026
Arthur J. Gallagher leads with 17.9% revenue growth while Grand Canyon Education and GE HealthCare struggle

Arthur J. Gallagher, an insurance brokerage and consulting firm, stands out amongst cash-producing stocks with a 12.8% trailing 12-month free cash flow margin. The company has demonstrated strong revenue growth of 17.9% annually over the past two years and earnings per share growth of 17.7% annually over five years, outperforming peers. In contrast, Grand Canyon Education faces challenges with underwhelming student numbers and modest earnings growth of just 7.2% annually over five years, despite a 21.6% free cash flow margin. GE HealthCare also struggles with weak 2.7% annual revenue growth over two years and limited organic expansion. Arthur J. Gallagher, operating in approximately 130 countries, provides insurance brokerage, reinsurance and consulting services globally.

INACTIVE